MedPath
NMPA Approval

Ibuprofen Suspension

国药准字H20244754

August 27, 2024

Drug Information

布洛芬混悬液

口服混悬剂

100ml:2g

化学药品

August 27, 2024

Company Information

Applicant Company

北京市顺义区中北工业区(北石槽镇)

Manufacturing Company

北京市顺义区中北工业区(北石槽镇)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

布洛芬混悬液 - NMPA 批准文号 | MedPath